Secchi, Ottavio, Andrea Franchi, and Armando Lunello. “Comments to ‘Cost Per Responder for Vedolizumab and Ustekinumab in Crohn’s Disease Patients After Failure of TNF-α Inhibitors in Italy’”. AboutOpen 10, no. 1 (June 5, 2023): 82–86. Accessed November 21, 2024. https://journals.aboutscience.eu/index.php/aboutopen/article/view/2600.